Moreover, the in vitro hyperglycemia model decreased the resistivity of the individual and dual MG and ECs barriers, while treatment with contemporary anti-VEGF compounds restored the resistivity of the dual cell barriers to those of the basal levels. This evidence concerns the gene VEGFA and Hyperglycemia.